organization

AB Analitica

AB ANALITICA SRL
  • project . 2016 - 2019
    Funder: EC Project Code: 687089
    Overall Budget: 2,906,800 EURFunder Contribution: 2,906,800 EUR
    Open Access mandate for Publications and Research Data
    Partners: ALACRIS, AB Analitica, UB, IIT, Université Paris-Sud

    The advent of analytical techniques with extremely low limits of detection has led to dramatic progresses mostly in the field of nucleic acids sequencing. Despite the advent of the next generation sequencing platforms, the current genome sequencing task remains formidab...

  • project . 2021 - 2024
    Funder: EC Project Code: 964995
    Overall Budget: 3,116,540 EURFunder Contribution: 3,116,540 EUR
    Open Access mandate for Publications and Research Data
    Partners: AB Analitica, TUM, University of Stuttgart, ELEMENTS SRL, IIT, CIC biomaGUNE, DNA SCRIPT SAS, THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE, Swiss Federal Institute of Technology in Zurich

    Modern society has an ever-increasing need for long-term, high density data encoding and storage. DNA technology allows to store data at unprecedented density, and functionalized DNA integrates digital bits placed along a single strand to encode information, which is av...

  • project . 2016 - 2021
    Funder: EC Project Code: 667403
    Overall Budget: 5,994,870 EURFunder Contribution: 5,994,870 EUR
    Open Access mandate for Publications and Research Data
    Partners: Institut Pasteur, THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE, TUCH, Karolinska Institutet Innovations (Sweden), UNITS, AB Analitica, HELSINGIN YLIOPISTO, ISTITUTO SUPERIORE DI SANITA, University of Turku

    The goal of this multidisciplinary project is to comprehensively characterise high-grade serous ovarian cancer (HGS-OvCa) at single-cell level, identify the best combination of drug combination to kill HGS-OvCa populations and commercialise a predictive biomarker kit fo...

  • project . 2021 - 2026
    Funder: EC Project Code: 965193
    Overall Budget: 14,999,300 EURFunder Contribution: 14,999,300 EUR
    Open Access mandate for Publications and Research Data
    Partners: AIFORIA TECHNOLOGIES OY, VEIL.AI OY, Karolinska Institutet Innovations (Sweden), HUS, UNIMORE, HELSINGIN YLIOPISTO, TUCH, Institut Pasteur, University Hospital Heidelberg, FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)...

    The goals of this inter-disciplinary project are to 1) gain understanding of the mechanisms causing chemoresistance in high-grade serous ovarian cancer (HGSOC) patients, 2) deliver tools that enable effective and cost-efficient personalised treatment options for HGSOC p...

Any information missing or wrong?Report an Issue